


The Journal of Diabetes, Metabolism and Endocrinology recognizes that generative artificial intelligence (AI) and AI-assisted technologies are increasingly used in research, manuscript preparation, peer review, data analysis, and scholarly communication. The journal supports responsible use of these technologies while maintaining human accountability, research integrity, transparency, confidentiality, and scientific accuracy.
This policy is informed by relevant principles and recommendations from the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).
Generative AI tools may be used as an assistive technology, provided that their use does not compromise the integrity, originality, confidentiality, or accuracy of scholarly work.
AI-generated or AI-assisted content must always be appropriately reviewed and verified by human authors or editors.
AI systems cannot assume responsibility for published research and therefore cannot be listed as authors or co-authors.
Authors remain fully responsible for the content of their manuscript, regardless of whether AI tools were used during its preparation.
Authors must:
Use of an AI tool does not transfer responsibility for the manuscript from the authors to the technology provider.
Subject to appropriate verification and disclosure, authors may use generative AI tools for limited assistance such as:
Authors remain responsible for verifying the resulting content.
Where generative AI materially contributes to the intellectual or textual development of a manuscript, authors should disclose its use.
Examples may include AI assistance with:
The disclosure should identify, where relevant:
Generative AI tools must not be listed as authors, co-authors, contributors with authorship status, or corresponding authors.
AI systems cannot:
Human authors remain accountable for all published content.
Authors must carefully review AI-generated text before incorporating it into a manuscript.
AI systems may generate:
Authors must independently verify the accuracy and scientific validity of AI-assisted material.
Authors are responsible for verifying every citation and reference generated or suggested by an AI system.
References must correspond to genuine and relevant scholarly sources.
Fabricated, inaccurate, irrelevant, or unverifiable references are unacceptable, regardless of whether they were generated by an AI tool.
Authors should not cite an AI system as a substitute for the original scholarly source when the original source is available.
Authors must not use generative AI tools in ways that compromise the confidentiality, security, or integrity of research data.
Particular caution is required for:
Authors should not upload confidential or identifiable research information to external AI services unless appropriate authorization, security, privacy, and data-protection safeguards are in place.
Because the journal publishes research related to medicine, diabetes, metabolism, and endocrinology, authors must exercise particular caution when AI tools are used with clinical or patient-related information.
AI assistance must not result in:
AI-generated clinical interpretations must be independently evaluated by appropriately qualified researchers or healthcare professionals.
Authors must disclose the use of generative AI to create or substantially modify images, figures, illustrations, or other visual material where such use is permitted.
AI-generated visual content must not:
The use of AI to manipulate research images or scientific evidence in a manner that changes the underlying findings may constitute research misconduct.
AI tools may assist researchers with coding, statistical workflows, or computational analysis.
However, authors remain responsible for:
Where AI makes a substantive contribution to computational analysis, appropriate disclosure is encouraged.
Reviewers must maintain strict confidentiality when using AI-assisted technologies.
Reviewers should not upload confidential manuscripts, unpublished research, reviewer reports, or other protected editorial information into public or external generative AI systems where confidentiality cannot be assured.
Reviewers remain responsible for the content and recommendations of their review.
AI tools must not replace the reviewer's independent scholarly judgment.
Editors may use appropriate AI-assisted tools for limited administrative or editorial purposes where confidentiality and data-protection requirements can be maintained.
AI systems must not independently make final decisions concerning:
Final editorial decisions must remain under the responsibility of qualified human editors.
AI-generated content may be considered as part of an editorial assessment, but AI-detection software or automated AI classifiers should not be treated as definitive evidence of misconduct on their own.
AI-detection results may produce false positives or false negatives.
Where concerns arise, the journal may consider:
Where disclosure is required, authors should include an appropriate statement in the manuscript.
For example:
“The authors used [name of AI tool] for language and/or editorial assistance during manuscript preparation. The authors reviewed and verified all AI-assisted content and remain fully responsible for the accuracy, originality, and integrity of the published work.”
The disclosure should accurately describe the actual use of AI and should not claim that AI was used when it was not.
AI-generated text does not automatically constitute plagiarism; however, authors remain responsible for ensuring originality and appropriate attribution.
Authors must not use generative AI to:
The journal may conduct plagiarism and similarity screening using appropriate tools.
Authors are responsible for ensuring that AI-assisted content complies with applicable copyright, licensing, intellectual-property, and attribution requirements.
Where third-party material is incorporated into AI-assisted output, authors must ensure that appropriate rights and permissions exist where required.
Failure to disclose substantive AI use where disclosure is required may constitute a publication-ethics concern.
If significant undisclosed AI use is identified, the journal may request clarification or take appropriate editorial action depending on the circumstances.
Potential actions may include:
The journal follows applicable COPE principles and guidance concerning AI-assisted scholarly publishing, confidentiality, authorship, peer review, and research integrity.
The journal also follows relevant ICMJE Recommendations regarding the use of AI and machine-learning tools in scholarly publishing, including the principles that authors remain responsible for the accuracy and integrity of their work and that AI tools cannot satisfy authorship requirements.
The Editorial Office may request information concerning the use of AI where it is relevant to:
Authors are expected to cooperate with reasonable editorial requests.
The Journal of Diabetes, Metabolism and Endocrinology supports responsible innovation in scholarly publishing but places human accountability above automated generation.
Generative AI may assist researchers, authors, reviewers, and editors, but it cannot replace qualified human judgment or responsibility. The use of AI must never compromise research integrity, patient confidentiality, scientific accuracy, originality, transparency, or ethical standards.
The journal reserves the right to update this policy as generative AI technologies, ethical standards, regulatory requirements, and international publishing guidance continue to evolve.


